Darenzepine |
Catalog No.GC31136 |
Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 84629-61-8
Sample solution is provided at 25 µL, 10mM.
Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.
Darenzepine is a muscarinic receptor inhibitor which is useful for the treatment of CNS disorders[1].
[1]. Eric Elenko, et al. Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation. US 20170095465 A1.
Average Rating: 5
(Based on Reviews and 28 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *